Resources

PATH has taken a holistic approach to assessing the current anemia interventions at the national level and identifying the key strategies required to strengthen the national Anemia Mukt Bharat (AMB) program for effective implementation.We have undertaken a series of activities to achieve our objectives. These included a rapid assessment of 15 states in India to gain insights into the barriers and enablers of the AMB program implementation, the use of living labs with a human-centric research design to co-design solutions from the perspectives of health care workers, key informant interviews, state-level consultation workshops, and a comprehensive review of the different components of the AMB program to develop landscape documents and reports.Through these concerted efforts, we produced a plethora of knowledge products including a compendium of state-level case studies and best practices of anemia interventions, a living labs report, landscape documents focusing on digital interventions for anemia, anemia diagnostics, treatment pathways, market understanding of Injection ferric carboxymaltose, and IEC material.

Hemoglobinopathies—including sickle cell disease (SCD), thalassemia, and other inherited blood disorders—are among the most common genetic conditions worldwide. More than 5% of the global population carries a gene associated with a hemoglobin disorder, resulting in an estimated 300,000–400,000 children being born annually with severe forms of these conditions.In India, hemoglobinopathies remain a major public health challenge, disproportionately affecting tribal, rural, and underserved communities. Many individuals continue to face barriers to early diagnosis, quality treatment, and long-term care.PATH works with governments, health care institutions, researchers, and communities to strengthen integrated hemoglobinopathy services through health systems strengthening, diagnostic innovation, capacity building, patient-centered care, and evidence generation. Our work spans prevention, screening, diagnosis, treatment, and long-term management, with a focus on building sustainable solutions within public health systems.Our work1. Addressing the burden of sickle cell disease in IndiaPATH is supporting governments in strengthening the prevention, diagnosis, treatment, and long-term management of sickle cell disease through health systems strengthening, innovative diagnostics, health care worker capacity building, improved access to treatment, and patient-centered support mechanisms. Working closely with public health systems and communities, the initiative aims to build sustainable models that improve access to quality care and strengthen the continuum of care for people living with SCD.In Maharashtra, PATH, in collaboration with the state's public health department, is supporting the National Sickle Cell Anaemia Elimination Mission (NSCAEM). PATH's work focuses on NSCAEM's comprehensive approach to addressing SCD through enhanced services and innovative strategies in high-prevalence districts, including Nandurbar and Gadchiroli.Read the project brief here2. Strengthening integrated hemoglobinopathy care with a focus on thalassemiaPATH is also working with state governments and partners to strengthen comprehensive thalassemia prevention and care through integrated screening strategies, early diagnosis, genetic counseling, patient management, and health systems strengthening. The initiative focuses on building scalable, evidence-based approaches that improve access to services and support long-term care within the public health system. This work is supported through Bristol Myers Squibb Foundation grant to tackle hemoglobinopathies in India, enabling PATH to accelerate progress across both states.Read the project brief here

To identify solutions that maximize the frequency and quality of early childhood development (ECD) counseling in health services, PATH employed its Living Labs model of human-centered design (HCD) with service providers, community members, and government stakeholders in Siaya County in Kenya and Monapo District in Mozambique’s Nampula Province. This 8-page brief details each step of PATH's HCD process and the resulting, co-created, ECD counseling solutions.

This brief provides an overview of program-based budgeting and associated performance frameworks, and advice on choosing oxygen-related indicators to include in program-based budgets. The content within this brief is general in nature and, in order to be implemented, will require adaptation to specific health systems based on their particular budget and health system structure. This document draws heavily on both the World Health Organization’s work on program-based budgeting, and PATH’s efforts on medical oxygen.

The digital directory of technologies for noncommunicable diseases and mental health in Asia-Pacific, developed by PATH under the Asian Development Bank’s guidance, aims to identify and catalog cost–effective, patient–centric technology innovations suitable for primary health care (PHC) settings.This directory focuses on screening, diagnosis, monitoring, and management of noncommunicable diseases (NCDs) and mental health conditions in low- and middle-income countries. By providing a comprehensive repository of scalable health technologies, the initiative seeks to enhance accessibility and affordability of care, particularly in rural and underserved areas, making PHCs more effective as the first point of contact for individuals.The directory serves as a searchable resource for stakeholders and external audiences, showcasing market–ready technologies for NCD and mental health care in the Asia–Pacific region. The development process involved thorough searches using specialized keywords on platforms like Google Scholar, Tracxn, Crunchbase, and Pitchbook, ensuring technologies met criteria for affordability, durability, ease of use, maintenance, and power requirements.Technologies are classified under major NCD categories (diabetes, chronic respiratory diseases, cardiovascular diseases, and cancer) and mental health diseases, with further categorization by diagnostic tools, digital diagnostics, AI/ML innovations, telemedicine platforms, e–referral tools, and labor–saving technologies.